Vera Therapeutics's market cap is currently $1.95B. The company's EPS TTM is $-1.2; its P/E ratio is ―; Vera Therapeutics is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-1.16. See an overview of income statement, balance sheet, and cash flow financials.
